CAS 190000-46-5

Levomedetomidine ((R)-4-[1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride)

CAS: 190000-46-5

Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoi

Formel: C₁₃H₁₆N₂·HCl

Farbe und Form: White Powder

Molekulargewicht: 200.13135

Ref: 45-1179344

5-[(1R)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole hydrochloride

CAS: 190000-46-5

Formel: C₁₃H₁₇ClN₂

Farbe und Form: Solid

Molekulargewicht: 236.7405

Ref: IN-DA00BB4D

Levomedetomidine-13C-d3 HCl

CAS: 190000-46-5

Formel: C₁₂₁₃CH₁₃D₃N₂·HCl

Farbe und Form: White To Off-White Solid

Molekulargewicht: 204.30 36.46

Ref: 4Z-M-6891

Levomedetomidine HCl

CAS: 190000-46-5

Formel: C₁₃H₁₆N₂·HCl

Farbe und Form: White To Off-White Solid

Molekulargewicht: 200.29 36.46

Ref: 4Z-M-682

Levomedetomidine Hydrochloride

CAS: 190000-46-5

Formel: C₁₃H₁₆N₂HCl

Molekulargewicht: 200.29 : 36.46

Ref: ST-EA-CP-M8001

Levomedetomidine Hydrochloride

Kontrolliertes Produkt

CAS: 190000-46-5

Formel: C₁₃H₁₆N₂·ClH

Farbe und Form: Neat

Molekulargewicht: 236.74

Ref: TR-L375713

Dexmedetomidine related compound A

Kontrolliertes Produkt

CAS: 190000-46-5

Dexmedetomidine related compound A is a chiral drug that has been identified as the active form of dexmedetomidine. Dexmedetomidine is a potent inhibitor of inflammation, and has been shown to be effective in reducing postoperative pain and improving lung function. Dexmedetomidine related compound A inhibits the production of c-reactive protein (CRP) and tumor necrosis factor-α (TNF-α) in human monocytes, which may contribute to its effects on inflammation.

Formel: C₁₃H₁₆N₂•HCl

Reinheit: Min. 98 Area-%

Farbe und Form: White Off-White Powder

Molekulargewicht: 236.74 g/mol

Ref: 3D-FD63747